LLY · Lilly(Eli) & Co
United States · RS rating 93 · As of 2026-10-14
| Price | 1,208.74 USD |
|---|---|
| 1-day change | +3.6% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 90 / 77 / 89 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 60 / 60 |
| Industry group (rank) | Medical-Diversified (32) |
| EPS growth Q/Q | +19.0% |
| Sales growth Q/Q | +9.6% |
| Distance from 52-week high | +5.6% |
| Market cap (USD) | $819.8B |